Paksoy, N. Et Al. 2022. Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.1 , 215-221.

Paksoy, N., Erdem, S., Karaca, M., Ak, N., Pehlivan, M., Yirgin, İ., ... Ozluk, Y.(2022). Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.1, 215-221.

Paksoy, Nail Et Al. "Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.1, 215-221, 2022

Paksoy, Nail Et Al. "Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.1, pp.215-221, 2022

Paksoy, N. Et Al. (2022) . "Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.1, pp.215-221.

@article{article, author={Nail Paksoy Et Al. }, title={Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year=2022, pages={215-221} }